Brian Nowosielski

To optimize vaccine strategies among young people with Down syndrome, researchers explore the prevalence of adequate immune responses following pneumococcal vaccination.

Through diabetes education and initiatives focused on community health care, Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, is making a difference for patients and the pharmacy profession.

Episode 4 of Wicked Good Cardiometabolic Chat explores SGLT2 inhibitors and their efficacy beyond diabetes outcomes alone.

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, discusses risks and approaches associated with severe insulin resistance among mothers and their children.

Due to humans’ physiologically premature nature, researchers explore maternal psychological distress and childhood neurodevelopment.

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, discusses the Touro University California, pharmacist-led Pharm2Home initiative.

Researchers explore OTC naloxone sales sold independently at pharmacies and programmatically from 2023 to 2024.

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, discusses his experience in diabetes care and how the pharmacist’s role has evolved throughout his professional career.

Lisa Schwartz, PharmD, discusses her general opinions regarding how the predicted success of the Medicare Drug Price Negotiation Program’s future implementation.

Lisa Schwartz, PharmD, discusses community pharmacies’ displeasure with provisions backing the Medicare Drug Price Negotiation Program.

Lisa Schwartz, PharmD, discusses the importance of the Medicare Transaction Facilitator as community pharmacies head into a new year of the Medicare Drug Price Negotiation Program.

The FDA releases its updated recommendations and scientific considerations for the demonstration of safety and efficacy among biosimilars and their reference products.

The final part of our interview with Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, focuses on the relationships between state- and federal-level PBM reform.

From the COVID-19 pandemic through state-by-state expansion of scope, pharmacists have tapped into a variety of their clinical skills to bolster patient outcomes in their communities.

In part 4 of our interview with Jennifer Griffin, PharmD, MS, she discusses different payer engagement models and the pharmacists’ ability to understand and improve medical billing tactics.

At the NCPA 2025 Annual Convention & Expo, Lucas Morgan, Esq, shareholder with Buchanan Ingersoll & Rooney, joined us to discuss ongoing PBM legislation in the state of Arkansas.

Alyssa Mack, PharmD, pharmacist at Gibbs Pharmacy and Compounding Center, discusses how expanding clinical services can simultaneously benefit patients and the pharmacy profession.

Leaders of the FDA, the US Department of Health and Human Services, and the Centers for Medicare & Medicaid Services announce new guidelines and a framework for less expensive biosimilar development.

Tara Pfund, PharmD, chief strategy officer with Cascadia Pharmacy Group, discusses the importance of pharmacy businesses to understand evolving and emerging health care technology.

Jennifer Griffin, PharmD, MS, clinical pharmacist at Harps Food Stores, Inc, discusses revenue cycle management and how it has developed within community pharmacy.

Alyssa Mack, PharmD, discusses events like the pandemic and new pharmacy laws that have allowed for an expansion of pharmacists’ scope of practice.

Andrew M. Peterson, PharmD, PhD, FCPP, discusses how behavioral health services in community pharmacy help patients receive care impacting all factors of their health and not just medications.

Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, shareholders with Buchanan Ingersoll & Rooney, discuss Utah’s pharmacy benefit manager pass-through rebate law.

Alyssa Mack, PharmD, pharmacist at Gibbs Pharmacy and Compounding Center in Tennessee, discusses her role in expanding clinical services within her practice.

Tara Pfund, PharmD, chief strategy officer with Cascadia Pharmacy Group, discusses the importance of automation and its emerging role in pharmacy practices.

Before delinking, pharmacy benefit managers were able to tie their fees to significantly high-priced medications, in turn receiving large percentages of compensation rather than flat, fixed fees.

With the constant financial hurdles businesses face, the community pharmacy industry has struggled with finding new ways to innovate within its practices.

Jennifer Griffin, PharmD, MS, clinical pharmacist at Harps Food Stores, Inc, discusses the basis of having reimbursement pathways in community pharmacy that consistently generate revenue.

Steve Moore, PharmD, owner of Condo Pharmacy in Plattsburgh, New York, discusses how well-developed partnerships with various stakeholders in the drug supply chain can improve patient care.

Andrew M. Peterson, PharmD, PhD, FCPP, discusses the growing opportunities for pharmacies to support patients’ behavioral health management.